Holdings of Invesco Biotechnology & Genome ETF
Invesco Exchange-Traded Fund Trust · Original filing · Compare with another fund · Report an error
- Net assets
- 281.9M $ including 282.1M $ in equities, 100.0 %
- Positions
- 30 in 2 countries
- Top ten
- 46.2 % of net assets
- Filed on
- Jul 31, 2026
Portfolio shape
Positions
| Rank | Company | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | Regeneron Pharmaceuticals Inc | 20,233 | 15.4M $ | 5.47 % |
| 2 | Amgen Inc | 38,223 | 14.7M $ | 5.22 % |
| 3 | CareDx Inc | 325,179 | 14.2M $ | 5.04 % |
| 4 | Vertex Pharmaceuticals Inc | 29,460 | 14.1M $ | 4.99 % |
| 5 | ROYALTY PHARMA PLC | 238,422 | 13.9M $ | 4.94 % |
| 6 | Biogen Inc | 66,507 | 13.5M $ | 4.79 % |
| 7 | Gilead Sciences Inc | 96,026 | 12.5M $ | 4.43 % |
| 8 | United Therapeutics Corp | 22,197 | 11.5M $ | 4.08 % |
| 9 | Bio-Techne Corp | 146,019 | 10.5M $ | 3.73 % |
| 10 | Illumina Inc | 48,231 | 9.9M $ | 3.51 % |
| 11 | Protagonist Therapeutics Inc | 70,055 | 9.6M $ | 3.40 % |
| 12 | Vericel Corp | 200,298 | 9.2M $ | 3.27 % |
| 13 | ALNYLAM PHARMACEUTICALS INC | 43,457 | 8.9M $ | 3.17 % |
| 14 | Incyte Corp | 72,136 | 8.6M $ | 3.06 % |
| 15 | Repligen Corp | 60,807 | 8.6M $ | 3.04 % |
| 16 | ACADIA Pharmaceuticals Inc | 329,464 | 8.5M $ | 3.02 % |
| 17 | Halozyme Therapeutics Inc | 101,929 | 8.4M $ | 2.98 % |
| 18 | QIAGEN NV | 197,087 | 8.2M $ | 2.89 % |
| 19 | BioMarin Pharmaceutical Inc | 132,461 | 8M $ | 2.82 % |
| 20 | Neurocrine Biosciences Inc | 44,979 | 7.5M $ | 2.66 % |
| 21 | Exelixis Inc | 140,144 | 7.4M $ | 2.64 % |
| 22 | BioCryst Pharmaceuticals Inc | 826,963 | 7.4M $ | 2.63 % |
| 23 | Veracyte Inc | 158,435 | 7.3M $ | 2.60 % |
| 24 | Collegium Pharmaceutical Inc | 207,352 | 7.3M $ | 2.60 % |
| 25 | OMEROS CORP | 601,237 | 7.1M $ | 2.52 % |
| 26 | PTC Therapeutics Inc | 103,541 | 7M $ | 2.50 % |
| 27 | AnaptysBio Inc | 121,247 | 6.5M $ | 2.29 % |
| 28 | SAREPTA THERAPEUTICS INC | 420,180 | 6.2M $ | 2.21 % |
| 29 | Ardelyx Inc | 1,120,704 | 5.5M $ | 1.97 % |
| 30 | LEGEND BIOTECH CORP | 237,196 | 4.4M $ | 1.56 % |
Sector breakdown
- Health care 38.7 %
- Unattributed 61.3 %
Titelia assigns each company to a sector, one by one. The unassigned share stays visible, under "Unattributed".
Currency breakdown
- USD 100.0 %
Each line is counted in its quoted currency, as the fund declares it.
Country breakdown
- United States 98.4 %
- Cayman Islands 1.6 %
Shares are computed on the fund's equities only.
| Rank | Country | Lines | Value | Share |
|---|---|---|---|---|
| 1 | United States | 29 | 277.7M $ | 98.44 % |
| 2 | Cayman Islands | 1 | 4.4M $ | 1.56 % |
Cite this page
Titelia. "Holdings of Invesco Biotechnology & Genome ETF". https://titelia.com/en/funds/S000003026